DarkMatter2bd
MedFuse, a data-driven solution to improve clinical development
Presenter: Vince DeChellis
Monday, September 9, 2019
Embassy Suites, Chesterbrook, Pennsylvania (directions)
|
About
|
DarkMatter2bd provides refined real-world data and planning to the life science and healthcare industry powered by a proprietary database, MedFuse™. A cloud-based business platform enables rapid decision-making and end user access to a wide range of data assets designed to complement R&D and marketing needs.
DarkMatter charts segments of health care data transforming it into actionable information using visualization tools and custom analytics. Health care provider relationships, professional activities and clinical data are cross matched to deliver new and valuable insights designed to improve outcomes. The use of an ever-increasing range of data assets, stemming from a rapidly growing Health Information Technical Ecosystem gives DarkMatter the opportunity to provide better results for both commercial and R&D initiatives.
3 Major Issues
|
- What are the obstacles in getting R&D to use claims and other data sets to improve clinical trial patient targeting and protocol assessments?
- Where do you see the use of real-world data going and what are the next components that DarkMatter should look to develop?
- What are some recommendations for DarkMatter to improve reach and awareness of our services?
Program:
|
6:30 - Cocktails & Dinner (Cash bar and special 2-entree buffet menu)
7:45 - Vince DeChellis, Co-Founder of DarkMatter2bd, will deliver "Elevator" Pitch to the Group
8:00 - A Panel will address three major issues crucial to helping the Company reach the next level.
9:00 - Open discussion: members and guests
|
 |
|
Slides
Audio
Video
Webcast
